Thais Baccili Cury Megid
Moncton,Canada
Overview
7
7
years of professional experience
1
1
Certification
Work History
Assistant Professor
Faculty of Medicine and Health Sciences of the University of Sherbrooke
Quebec, Canada
12.2024 - Current
- Department of Medicine, Hematology and Oncology
Medical Oncologist
Dr. Georges-L.-Dumont University Hospital Centre
Moncton, Canada
06.2024 - Current
- Division of Medical Oncology and Hematology
Clinical Research Fellowship
Princess Margaret Cancer Centre, University of Toronto
Toronto, Canada
04.2022 - 05.2024
- Gastrointestinal Malignancies Department
Medical Oncologist
Hospital Sirio Libanes
São Paulo, Brazil
02.2021 - 02.2022
- Gastrointestinal Malignancies
Hospitalist
Hospital 9 de julho
São Paulo, Brazil
03.2019 - 01.2022
- Internal Medicine Department
Education
Veteran Affairs Quality Scholar (VAQS) Fellowship - Quality Improvement and Patient Safety
University of Toronto
Toronto, ON, Canada05.2025
Clinical Research Fellowship - Gastrointestinal Malignancies
University of Toronto
Toronto, ON, Canada05.2024
Medical Oncology Residency (PGY3/PGY4/PGY5) -
Hospital Sirio Libanes
Sao Paulo, Brazil02.2021
Internal Medicine Residency (PGY1/PGY2) -
Hospital Sirio Libanes
Sao Paulo, Brazil02.2018
Internship -
Universidade São Francisco (USF)
Sao Paulo, Brazil06.2015
BS and M.D -
Universidade São Francisco (USF)
Sao Paulo, Brazil06.2013
Professional Associations
- Brazilian Society of Clinical Oncology (SBOC), 2018-Current
- American Society of Clinical Oncology (ASCO), 2018-Current
- European Society of Medical Oncology (ESMO), 2018-Current
- New Brunswick Medical Society (NBMS), 2024-Current
Affiliations
- Defined Medical License 2024 (Medical Oncologist) | College of Physicians and Surgeons of New Brunswick, Canada (CPSNB 50243)
- Postgraduate Medical License 2022 (Clinical Fellow) | College of Physicians and Surgeons of Ontario, Canada (CPSO 135836)
- Medical Oncology and Hematology License Specialty | Regional Council of Medicine of São Paulo, Brazil (RQE 95083)
- Internal Medicine License Specialty | Regional Council of Medicine of São Paulo, Brazil (RQE 95082)
- General Medical License | Regional Council of Medicine of São Paulo, Brazil (CRM 174261)
Accomplishments
- Addressing Financial Toxicity and quality of life in cancer patients in New Brunswick.
2025, DUO Grant $20,000.00 CAD
Principal Investigator - PALLAS: Palbociclib Collaborative Adjuvant Study.
Principal Investigator - Implementation of Universal germline testing program for breast cancer in New Brunswick: Phase 1. NB UNIBRACA-1. Co-Investigator
Certification
- Consultative Member, Provincial Formulary of Oncological Medications of New Brunswick, Canada (Present)
- Founder and Responsible for the Quality Improvement and Patient Safety Rounds at Dr. Leon-Richard Cancer Center, Moncton, Canada (Present)
Peer-reviewed publications - 1st authorship publications
- Thais Baccili Cury Megid. "Clinical and Molecular features in Gastroesophageal patients Brain Metastases and Leptomeningeal Carcinomatosis." Journal of Neuro-Oncology (Impact Factor 4.5). Approved for publication January 2024.
- Thais Baccili Cury Megid. "Integrating patient-reported-outcomes into prognostication in gastroesophageal cancer: Results of a population-based retrospective cohort analysis." The Oncologist (Impact Factor 5.83). Approved for publication January 2024.
- Thais Baccili Cury Megid; Abdul Farooq; Xin Wang; Elena Elimova. "Gastric cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics." DOI: 10.3390/cancers15205075. IF 6.575.
- Thais Baccili Cury Megid; Barros-filho MC; Pisani JP; Achatz MI. "Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer." Frontiers Oncol 2022; 12:873395. Impact Factor 5.738.
Peer-reviewed publications -Senior authorship publications
- Carlos Diego Holanda; Ana Carolina Veneziani; Camila Xavier Branganca; Carlos Torrado Martin; Thais Baccili Cury Megid. "A comprehensive Exploration of Agents Targeting Tumor Microenvironment - Challenges and Future Perspectives." Journal of Immunotherapy and Precision Oncology, September 2024. DOI:10.36401/JIPO-24-23.
- Leite, L.F.; Noronha, M.M.; de Menezes, J.S.A.; da Conceição, L.D.; Almeida, L.F.C.; Cappellaro, A.P.; Belotto, M.; Biachi de Castria, T.; Peixoto, R.D.; Baccili Cury Megid, T. "Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance." Cancers 2025, 17, 2804. DOI: 10.3390/cancers17172804. Impact Factor 5.3.
Peer-reviewed publications - Co-authorship publications
- Luís Felipe Leite da Silva, et al., Thais Baccili Cury Megid. "Disease Free survival as a surrogate endpoint for overall survival in adults with early stage pancreatic cancer: a trial level surrogacy analysis." DOI: 10.1136/bmjonc-2025-000766. IF 10.9.
- Yvonne Bach, et al., Thais Baccili Cury Megid, et al., "Real-world study of ramucirumab and paclitaxel in second or greater lines of therapy in patients with HER2-positive gastroesophageal cancer." The Oncologist, Volume 30, Issue 3, March 2025. DOI: 10.1093/oncolo/oyaf037. IF 5.3.
- Mariana Macambira Noronha, et al., Thais Baccili Cury Megid, et al., "Peritoneal Tumor DNA as a Prognostic Biomarker in Pancreatic Cancer: A Systematic Review and Meta-Analysis." Pancreas. November 2024. Impact Factor 2.9.
- Jennifer Leigh, et al., Thais Baccili Cury Megid, et al., "Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024." Current Oncology 32, no. 3: 175. DOI: 10.3390/curroncol32030175. IF 6.575.
- Yvonne Bach, et al., Thais Baccili Cury Megid, et al., "First Impressions: a prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation." Cancer Medicine. Impact Factor 3.89.
- Leandro Jonata Carvalho Oliveira, Larissa Costa Amorim, Thais Baccili Cury Megid, et al., "Gene expression signatures in early breast cancer: Better together with clinicopathological features." Critical Reviews in Oncology Hematology, Volume 175, 2022. Impact Factor 6.312.
- Oliveira LJC, Megid TBC, Rosa DD, et al. "Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study." Therapeutic Advances in Medical Oncology. 2022;14. Impact Factor 5.02.
- Vieira, Aline Cristini; Megid, Thais Baccili Cury; Melo, Raissa; et al. "Response To Anti-Pd1 Immunotherapy in Patients with Metastatic Cutaneous Sarcoma: Case Reports and Literature Review." Oxford Medical Case Reports, 2020.
Manuscripts in Preparation
- De novo metastatic versus recurrent gastroesophageal cancers: A single- centre retrospective analysis. (To be submitted in October 2024).
- Clinical and Molecular Features and Survival in Thyroid Cancer with Brain Metastases.
- Neoadjuvant Immune Checkpoint Blackade in resectable Hepatocellular carcinoma: A systematic Review and Meta-Analysis.
Oral Presentations
- 2023 - "Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: A real-world analysis of outcomes, clinical and pathologic characteristics." Research Day, University of Toronto (Presenter)
- 2019 - "Epidemiology of central nervous system metastases in patients with lung adenocarcinoma harboring oncogenic driver alterations." XX-Congresso da Sociedade Brasileira de Oncologia 2019 (Presenter)
- 2019 - "Oncotype DX testing in early-stage breast cancer and impact in chemotherapy use: a report from a reference cancer center in Brazil." XX- Congresso da Sociedade Brasileira de Oncologia Clínica 2019 (Presenter)
Poster Presentations
- 2025 - "Pathological Complete Response in Gastroesophageal Cancer Trials: A reliable Surrogate for Overall Survival?" ESMO 2025 (Senior Author)
- 2025 - "Disease-free survival as a surrogate endpoint for overall survival in adults with early-stage pancreatic cancer: A trial-level surrogacy analysis." ASCO Gastrointestinal 2025 (ASCO Merit Award 2025)
- 2024 - "Real world comparison of ≥2nd line ramucirumab and paclitaxel in HER2-positive and HER2-negative gastroesophageal cancer." ESMO GI
- 2024 - "Clinical and Molecular Features and Survival in Thyroid Cancer with Brain Metastases." ASCO 2024
- 2024 - "De novo metastatic versus recurrent gastroesophageal cancer: A single-centre retrospective analysis." ASCO GI
- 2023 - "Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: A real-world analysis of outcomes, clinical and pathologic characteristics." ASCO Annual Meeting 2023 (Presenter, ASCO Merit Award 2023)
- 2023 - "Brain metastases in Advanced Thyroid Carcinoma: Clinical and Molecular Characteristics and Outcomes." ESMO CONGRESS MADRID 2023 (Presenter)
- 2023 - "First Impressions: a prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation." ESMO CONGRESS MADRID 2023
- 2023 - "Real- world eligibility for adjuvant CDK4/6 inhibitors among patients without genomic risk for chemotherapy: a GBECAM multicenter retrospective study." San Antonio Breast Cancer Symposium 2023
- 2023 - "Integrating patient-reported-outcomes into prognostication in gastroesophageal cancer: Results of a population-based retrospective cohort analysis." ASCO GI (Presenter)
- 2023 - "Pre-diagnostic delay among patients with curative esophageal and gastric cancer during the COVID-19 pandemic." ASCO GI 2023
- 2021 - "Double heterozygous pathogenic variants prevalence in a cohort of hereditary breast cancer patients." San Antonio Breast Cancer Symposium 2021 (Presenter)
- 2019 - "Incidence of second primary malignancies in patients with sporadic desmoid tumors." XX congresso da sociedade Brasileira de oncologia Clínica 2019 (Presenter)
- 2019 - "Prediction of the High-risk Oncotype Dx recurrence score from clinicopathologic factors: a report from a Cancer Reference Center in Brazil." San Antonio Breast Cancer Symposium 2019
- 2022 - "Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: A GBECAM multicenter retrospective study." Journal of Clinical Oncology, 2022. 2022 ASCO Annual Meeting.
- 2023 - "The prognostic value of degree of pre- and post-treatment anemia in patients with advanced gastroesophageal cancers." Journal of Clinical Oncology, 2023-06. 2023 ASCO Annual Meeting.
Presentations and Special Lectures (Invited Speaker)
- International
2023 - "Brain Metastases in Gastrointestinal Malignancies." Universidade Federal de Sao Paulo (UNIFESP), Neuro-oncology Fellowship. Brazil.
2021 - "Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal." Brazil.
2021 - "Systemic treatment in CCR: Treatment in adjuvant and metastatic setting updates." Post-Graduation in Coloproctology Program at Hospital Sirio Libanes. Brazil.
2021 - "Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer (Keynote-177)." ASCO 2021 highlights by Merck. Brazil.
2020 - "Neuroendocrine Tumors- Case Reports and Discussions." Online Conference Hospital Sirio Libanês and Memorial Sloan Kettering Cancer Center. Brazil/USA.
2019 - "Homologous recombination deficiency in diverse cancer types." Latin America Hereditary Meeting, Grupo de Estudios de Tumores Hereditários de Latin America (LAGETH). Latin America. - Local (Canada)
2025 - "ASCO updates 2025, Highlights in GI malignancies." Moncton, Canada.
2025 - "Post-ASCO GI 2025 updates." Moncton, Canada.
2024 - "Recent updates in GI-related malignancies a case-based review." Moncton, Canada.
2024 - "Breaking Barriers in Brain Metastases." London, Ontario, Western University.
2023 - "Oncologic Emergencies." Mount Sinai Hospital. Canada.
2022 - "Case Based Teaching – Pancreatic Adenocarcinoma." University of Toronto. Canada.
Book Chapter
- 2018 - MEGID, T. B. C.; HENARES, B.; BAGNATO, M. Augusto Scalabrini (Org.). "Síndrome da apneia obstrutiva do sono." Medicina Interna (Internal Medicine) 2 ed. Manole.
Teaching and Tutoring
- 2024-Present | Assistant Professor, Faculty of Medicine and Health Sciences of the University of Sherbrooke - Department of Medicine, Hematology and Oncology, Quebec, Canada
- 2024-Present | Mentoring Medical Students from Brazil writing peer-reviewed manuscripts and metanalyses.
- 2024-Present | Breast Cancer updates and teaching to GPOs, Moncton, New Brunswick. Canada
- 2023-2024 | Medical Oncology Residency teaching – Case-based discussion Block- University of Toronto, Canada
- 2023-2024 | Internal Medicine Residency teaching – Oncology Block- Mount Sinai Hospital, Canada
- 2021-2022 | Tutoring for Medical Oncology Residents. Hospital Sirio Libanes, Brazil
Certificates
- 2023 - ASCO-AIOM International Clinical Research Course, Rome (April 2023)
- 2020-2021 - Palliative Care Post-Graduation - Hospital Sirio Libanes, Sao Paulo, Brazil
Awards
- ASCO Merit Award 2023, $1,000
Languages
- Portuguese – Native Speaker
- English – Fluent
- Spanish – Fluent
- French – Basic proficiency
Timeline
Assistant Professor
Faculty of Medicine and Health Sciences of the University of Sherbrooke
12.2024 - Current
Medical Oncologist
Dr. Georges-L.-Dumont University Hospital Centre
06.2024 - Current
Clinical Research Fellowship
Princess Margaret Cancer Centre, University of Toronto
04.2022 - 05.2024
Medical Oncologist
Hospital Sirio Libanes
02.2021 - 02.2022
Hospitalist
Hospital 9 de julho
03.2019 - 01.2022
Veteran Affairs Quality Scholar (VAQS) Fellowship - Quality Improvement and Patient Safety
University of Toronto
Clinical Research Fellowship - Gastrointestinal Malignancies
University of Toronto
Medical Oncology Residency (PGY3/PGY4/PGY5) -
Hospital Sirio Libanes
Internal Medicine Residency (PGY1/PGY2) -
Hospital Sirio Libanes
Internship -
Universidade São Francisco (USF)
BS and M.D -
Universidade São Francisco (USF)
Similar Profiles
Rebecca (Bec) NowlandRebecca (Bec) Nowland
Medicine Program Tutor at Bond University Faculty Of Health Sciences & MedicineMedicine Program Tutor at Bond University Faculty Of Health Sciences & Medicine
Dr Thomas Kana @ Kamarudin KanaDr Thomas Kana @ Kamarudin Kana
Head of Family Medicine Department at Faculty of Medicine and Health Sciences, Universiti Malaysia SarawakHead of Family Medicine Department at Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak
OYOT-OBASI OJONG ARREYOYOT-OBASI OJONG ARREY
Dermatology Resident at Faculty of Medicine and Biomedical Sciences, University of Yaoundé IDermatology Resident at Faculty of Medicine and Biomedical Sciences, University of Yaoundé I
Juliet MbakwemJuliet Mbakwem
Counsellor at Camp rotaryCounsellor at Camp rotary
Melissa WallsMelissa Walls
Assistant Manager at Toys R UsAssistant Manager at Toys R Us